Andreas Schwarzer

Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin’s lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19)

Michael Herold, Antina Schulze, Dietger Niederwieser et al. · Journal of Cancer Research and Clinical Oncology · 2005 · 103 citations · Full text

Lymphoid Neoplasia, Oncology, Mantle Cell Lymphoma +8

Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem‐cell transplantation or conventional chemotherapy: results of a Phase I clinical trial

Wolfram Pönisch, Marta Rozanski, Hartmut Goldschmidt et al. · British Journal of Haematology · 2008 · 82 citations · Full text

Cell Replacement Therapy, Pharmacotherapy, Autologous Stem‐cell Transplantation +17

The desire for shared decision making among patients with solid and hematological cancer

Jochen Ernst, Susanne Kuhnt, Andreas Schwarzer et al. · Psycho-Oncology · 2010 · 54 citations

Successful treatment of patients with newly diagnosed/untreated multiple myeloma and advanced renal failure using bortezomib in combination with bendamustine and prednisone

Wolfram Pönisch, Marc Andrea, Ina Wagner et al. · Journal of Cancer Research and Clinical Oncology · 2012 · 48 citations · Full text

Hematological Malignancy, Urology, Successful Treatment +9

Sleep-disordered breathing decreases after opioid withdrawal

Andreas Schwarzer, Marie Aichinger-Hinterhofer, Christoph Maier et al. · Pain · 2015 · 47 citations